UniProt ID | LY96_HUMAN | |
---|---|---|
UniProt AC | Q9Y6Y9 | |
Protein Name | Lymphocyte antigen 96 | |
Gene Name | LY96 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 160 | |
Subcellular Localization | Secreted, extracellular space . Secreted . Retained in the extracellular space at the cell surface by interaction with TLR4 (PubMed:10359581). | |
Protein Description | Binds bacterial lipopolysaccharide (LPS). [PubMed: 17803912] | |
Protein Sequence | MLPFLFFSTLFSSIFTEAQKQYWVCNSSDASISYTYCDKMQYPISINVNPCIELKRSKGLLHIFYIPRRDLKQLYFNLYITVNTMNLPKRKEVICRGSDDDYSFCRALKGETVNTTISFSFKGIKFSKGKYKCVVEAISGSPEEMLFCLEFVILHQPNSN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
22 | Phosphorylation | FTEAQKQYWVCNSSD HHHHHHHEEEECCCC | 13.57 | - | |
26 | N-linked_Glycosylation | QKQYWVCNSSDASIS HHHEEEECCCCCEEE | 34.62 | 17569869 | |
42 | Phosphorylation | TYCDKMQYPISINVN EECCCCCCEEEEEEC | 10.07 | 25002506 | |
45 | Phosphorylation | DKMQYPISINVNPCI CCCCCEEEEEECCCE | 12.01 | 25002506 | |
114 | N-linked_Glycosylation | ALKGETVNTTISFSF HHCCCEECEEEEEEE | 38.64 | 17569869 | |
120 | Phosphorylation | VNTTISFSFKGIKFS ECEEEEEEECCCEEC | 21.18 | 24719451 | |
131 | Phosphorylation | IKFSKGKYKCVVEAI CEECCCEEEEEEEEC | 20.49 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LY96_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LY96_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TLR4_HUMAN | TLR4 | physical | 11976338 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Crystal structures of human MD-2 and its complex with antiendotoxiclipid IVa."; Ohto U., Fukase K., Miyake K., Satow Y.; Science 316:1632-1634(2007). Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 17-160 IN COMPLEX WITH LIPIDIV-A, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-26 AND ASN-114. |